MedMesh.i
Corpus
Accueil
Racine
Corpus
Exploration
Accueil
Racine
Accueil

Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « MedMesh.i » - entrée « Immunomodulation »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Immunologic Factors < Immunomodulation < Immunophenotyping  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000259 (2021) Ales Janda ; Catharina Schuetz ; Scott Canna ; Mark Gorelik ; Maximilian Heeg ; Kirsten Minden ; Claas Hinze ; Ansgar Schulz ; Klaus-Michael Debatin ; Christian M. Hedrich ; Fabian SpethTherapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists.
000396 (2021) Fanny Onodi ; Lucie Bonnet-Madin ; Laurent Meertens ; Léa Karpf ; Justine Poirot ; Shen-Ying Zhang ; Capucine Picard ; Anne Puel ; Emmanuelle Jouanguy ; Qian Zhang ; Jérôme Le Goff ; Jean-Michel Molina ; Constance Delaugerre ; Jean-Laurent Casanova ; Ali Amara ; Vassili SoumelisSARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.
000807 (2020) Antonio Cassone ; Licia Iacoviello ; Roberto CaudaKnowing more about chloroquine/hydroxycloroquine in COVID-19 patients.
000B17 (2020) Burak PamukçuInflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2.
000B37 (2020) Joana Vitte ; Moïse Michel ; Soraya Mezouar ; Aïssatou Bailo Diallo ; Asma Boumaza ; Jean-Louis Mege ; Benoit DesnuesImmune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines.
000C59 (2020) Daniel R. Burrage ; Soraya Koushesh ; Nidhi SofatImmunomodulatory Drugs in the Management of SARS-CoV-2.
000D66 (2021) E. Díaz ; R. Amézaga Menéndez ; P. Vidal Cortés ; M G Escapa ; B. Suberviola ; A. Serrano Lázaro ; P. Marcos Neira ; M. Quintana Díaz ; M. Catalán González[Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)].
000F67 (2021) Kevin L. Winthrop ; Amanda E. Brunton ; Susan Beekmann ; Philip Polgreen ; John Baddley ; Kenneth G. Saag ; Cassandra Calabrese ; Leonard Calabrese ; Philip C. Robinson ; Zachary S. Wallace ; Jeffrey R. CurtisSARS CoV-2 infection among patients using immunomodulatory therapies.
001082 (2020) John G. Rizk ; Kamyar Kalantar-Zadeh ; Mandeep R. Mehra ; Carl J. Lavie ; Youssef Rizk ; Donald N. ForthalPharmaco-Immunomodulatory Therapy in COVID-19.
001126 (2020) Laurel C. Chandler ; Imran H. Yusuf ; Michelle E. Mcclements ; Alun R. Barnard ; Robert E. Maclaren ; Kanmin XueImmunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy.
001280 (2020) Giulia Iannaccone ; Roberto Scacciavillani ; Marco Giuseppe Del Buono ; Massimiliano Camilli ; Claudio Ronco ; Carl J. Lavie ; Antonio Abbate ; Filippo Crea ; Massimo Massetti ; Nadia AspromonteWeathering the Cytokine Storm in COVID-19: Therapeutic Implications.
001298 (2021) Rupesh Agrawal ; Ilaria Testi ; Cecilia S. Lee ; Edmund Tsui ; Marian Blazes ; Jennifer E. Thorne ; Annabelle A. Okada ; Justine R. Smith ; Peter J. Mccluskey ; John H. Kempen ; Christoph Tappeiner ; Manisha Agarwal ; Bahram Bodaghi ; Quan Dong Nguyen ; Vishali Gupta ; Marc D. De Smet ; Manfred Zierhut ; Carlos PavesioEvolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic.
001777 (2020) Jaume Alijotas-Reig ; Enrique Esteve-Valverde ; Cristina Belizna ; Albert Selva-O'Callaghan ; Josep Pardos-Gea ; Angela Quintana ; Arsene Mekinian ; Ariadna Anunciacion-Llunell ; Francesc Mir MurImmunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.
001866 (2020) Anca D. Askanase ; Leila Khalili ; Jill P. BuyonThoughts on COVID-19 and autoimmune diseases.
001928 (2020) Carlo Perricone ; Paola Triggianese ; Elena Bartoloni ; Giacomo Cafaro ; Angelo F. Bonifacio ; Roberto Bursi ; Roberto Perricone ; Roberto GerliThe anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.
001944 (2020) Ming ZhaoCytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies.
001945 (2020) Sun Hee Lee ; Hyunjin Son ; Kyong Ran PeckCan post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals?
001A20 (2020) Ashley Barlow ; Kaitlin M. Landolf ; Brooke Barlow ; Siu Yan Amy Yeung ; Jason J. Heavner ; Cassidy W. Claassen ; Mojdeh S. HeavnerReview of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Immunomodulation" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Immunomodulation" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Immunomodulation
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021